Evidence map›Paper›PMID 40117176›Full record

ArticleGigaScience2025

Healthy microbiome-moving towards functional interpretation.

Kinga Zielińska, Klas I Udekwu, Witold Rudnicki, Alina Frolova, Paweł P Łabaj

Abstract read
In one paragraph

Article in GigaScience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Analysis of metagenomic data.Nature reviews. Methods primers · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Kinga ZielińskaMałopolska Centre of Biotechnology, Jagiellonian University, 30-387 Krakow, Poland.ORCID 0000-0003-3278-1190
Klas I UdekwuDepartment of Biological Sciences, Bioinformatics and Computational Biology Program, University of Idaho, Moscow, ID 83843, USA.ORCID 0000-0002-8434-0744
Witold RudnickiFaculty of Computer Science, University of Białystok, 15-351 Białystok, Poland.ORCID 0000-0002-7928-4944
Alina FrolovaInstitute of Molecular Biology and Genetics of National Academy of Sciences of Ukraine, 03143 Kyiv, Ukraine.ORCID 0000-0001-5469-7366
Paweł P ŁabajMałopolska Centre of Biotechnology, Jagiellonian University, 30-387 Krakow, Poland.ORCID 0000-0002-4994-0234

Funding

Jagiellonian University in Krakow PLG/2023/016234NCN 2020/38/E/NZ2/00598
6 · The paper itself

Abstract

backgroundMicrobiome-based disease prediction has significant potential as an early, noninvasive marker of multiple health conditions linked to dysbiosis of the human gut microbiota, thanks in part to decreasing sequencing and analysis costs. Microbiome health indices and other computational tools currently proposed in the field often are based on a microbiome's species richness and are completely reliant on taxonomic classification. A resurgent interest in a metabolism-centric, ecological approach has led to an increased understanding of microbiome metabolic and phenotypic complexity, revealing substantial restrictions of taxonomy-reliant approaches.

findingsIn this study, we introduce a new metagenomic health index developed as an answer to recent developments in microbiome definitions, in an effort to distinguish between healthy and unhealthy microbiomes, here in focus, inflammatory bowel disease (IBD). The novelty of our approach is a shift from a traditional Linnean phylogenetic classification toward a more holistic consideration of the metabolic functional potential underlining ecological interactions between species. Based on well-explored data cohorts, we compare our method and its performance with the most comprehensive indices to date, the taxonomy-based Gut Microbiome Health Index (GMHI), and the high-dimensional principal component analysis (hiPCA) methods, as well as to the standard taxon- and function-based Shannon entropy scoring. After demonstrating better performance on the initially targeted IBD cohorts, in comparison with other methods, we retrain our index on an additional 27 datasets obtained from different clinical conditions and validate our index's ability to distinguish between healthy and disease states using a variety of complementary benchmarking approaches. Finally, we demonstrate its superiority over the GMHI and the hiPCA on a longitudinal COVID-19 cohort and highlight the distinct robustness of our method to sequencing depth.

conclusionsOverall, we emphasize the potential of this metagenomic approach and advocate a shift toward functional approaches to better understand and assess microbiome health as well as provide directions for future index enhancements. Our method, q2-predict-dysbiosis (Q2PD), is freely available (https://github.com/Kizielins/q2-predict-dysbiosis).

Indexed as

Gastrointestinal MicrobiomeInflammatory Bowel DiseasesMetagenomicsMicrobiotaComputational BiologyDysbiosisHumansPhylogenyPrincipal Component Analysisdysbiosisgut microbiome healthhealth indexmetagenomicsmicrobiome

Identifiers

PMID40117176
PMCPMC11927397

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.